- Overview
- MASLD and MASH
- Tests & Diagnosis
- Treatment and Prevention
- Complications
- Appointment Prep
- View Full Guide
Fatty Liver Symptoms in Women


Understanding Fatty Liver Disease
Fatty liver disease happens when too much fat builds up in your liver. People who are overweight or have obesity have a higher risk of fatty liver disease, as do those with type 2 diabetes, high cholesterol, and high triglycerides. Alcohol use disorder also can lead to it. Women are less likely to have it before turning 50. After menopause, however, women are about 20% more likely than men to get fatty liver disease and have it become a more advanced liver disease.

Why Women Should Pay Attention
After menopause, your risk increases as estrogen levels drop. Estrogen helps manage body fat and protect your liver. Women with polycystic ovary syndrome (PCOS) also face higher risks due to insulin resistance and hormonal imbalances that can lead to fat buildup in the liver. Women who have fatty liver disease also die from heart problems more than men. By age 60, their risk of heart disease is twice as high as that of men at that age.

Common Signs to Watch For
Early fatty liver disease often has no symptoms, making it a ”silent” condition. When symptoms do appear, you might feel tired all the time, have belly pain, or have a full feeling in the upper right part of your belly, where your liver is located. If you have fatty liver that has gotten worse, you could have jaundice (yellowing of your skin and the whites of your eyes), shortness of breath, swelling in your legs, or other symptoms.

Abdominal Changes
Pay attention to your midsection. Women with fatty liver disease often develop more belly fat, even if they haven't gained weight elsewhere. This isn't just regular weight gain — it's specifically around your middle. You might notice your pants fitting differently or abdominal swelling that seems out of proportion to the rest of your body.

Fatigue That Won't Go Away
Feeling exhausted even after a full night's sleep? Persistent fatigue is one of the most common fatty liver symptoms in women. Your liver works harder when it's filled with fat, which can drain your energy. This isn't the normal tiredness from a busy day — it's a deep exhaustion that rest doesn't seem to fix.

Hormone Connection
During menopause, declining estrogen leads to changes in fat distribution and metabolism that can trigger fatty liver development. Some women notice symptoms like weight gain, particularly around the abdomen, and increased fatigue during this transition. Hormone replacement therapy (HRT) may help some women manage these changes. However, experts don't yet know whether HRT protects against fatty liver disease.

Skin Changes
Check your skin for clues. Some women with advanced fatty liver disease develop yellowing of the skin or eyes (jaundice), itchy skin, or reddened palms. Spider-like blood vessels might appear on your skin. These changes happen when your liver isn't filtering toxins properly.

PCOS and Liver Health
Women with polycystic ovary syndrome (PCOS) have a higher risk of developing fatty liver disease due to insulin resistance and hormonal imbalances. If you have PCOS and experience unexplained fatigue, abdominal discomfort, or weight changes, talk to your doctor about checking your liver health.

Testing and Diagnosis
Fatty liver may be diagnosed accidentally during routine blood tests, or perhaps an abdominal ultrasound to check for something else that was making you sick, such as gallstones. Aside from blood tests, doctors use imaging tests and sometimes a liver biopsy to diagnose fatty liver. Be open with your doctor about all symptoms, even ones that seem unrelated.

Steps for Liver Health
The good news is that fatty liver disease can often be improved or reversed with lifestyle changes. Lose weight if you're not at a healthy weight. Avoid alcohol, which can make fatty liver worse. Get at least 150 minutes of exercise a week. Only one drug, resmetirom (Rezdiffra), has been approved by the FDA to treat the type of liver scarring that happens with metabolic dysfunction-associated steatohepatitis (MASH), an advanced form of fatty liver disease.
PHOTO CREDENTIALS
S1 - magicmine / Getty Images
S2 - MMD Creative / Shutterstock
S3 - fizkes / Shutterstock
S4 - ARMMY PICCA / Shutterstock
S5 - Andrey_Popov / Shutterstock
S6 - Prostock-studio / Shutterstock
S7 - AstroStar / Shutterstock
S8 - HenadziPechan / Shutterstock
S9 - Babul Hosen / Shutterstock
S10 - Sabrina Bracher / Getty Images
SOURCES:
JHEP Reports: “Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts.”
Mayo Clinic: “Nonalcoholic fatty liver disease,” “Cirrhosis,” “Metabolic syndrome.”
Johns Hopkins Medicine: “Nonalcoholic Fatty Liver Disease.”
Cleveland Clinic: “Steatotic (Fatty) Liver Disease,” “Adult Jaundice,” “Ascites,” “Peritoneum,” “Hepatic Encephalopathy,” “Acute Fatty Liver of Pregnancy,” “Hemorrhage,” “Cholestasis of Pregnancy,” “Obstructive Sleep Apnea,” “Turner Syndrome,” “Hormone Replacement Therapy (HRT).”
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): “Cirrhosis,” “Definition & Facts of NAFLD & NASH.”
World Journal of Hepatology: “Malnutrition in cirrhosis: More food for thought.”
American Liver Foundation: “Nonalcoholic Fatty Liver Disease (NAFLD).”
StatPearls: “Spider Angioma.”
Fibroid Fighters Foundation: “Liver Disease and Periods.”
Endocrine Society: “Women with irregular periods may be at risk for liver disease.”
Euroasian Journal of Hepato-Gastroenterology: “Gender Differences in Nonalcoholic Fatty Liver Disease.”
Osmosis: “Hypogonadism.”
LiverTox: “Tamoxifen.”
FDA: “FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease.”
Cleveland Clinic: “Steatotic (Fatty) Liver Disease,” “Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).”
Current Vascular Pharmacology: “Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.”
Endocrine Journal: “The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation.”
Endocrinology: “NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.”
Harvard Health Publishing: “Preventable liver disease is rising: What you eat – and avoid – counts.”
Healthcare: “The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease.”
Hepatobiliary Surgery and Nutrition: “Fatty liver disease in diabetes mellitus.”
Journal of Internal Medicine: "Current treatment of non-alcoholic fatty liver disease.”
Journal of Obstetrics and Gynaecology: “Changes of liver enzymes and triglyceride during the menopausal transition in Japanese women.”
Mayo Clinic: “Nonalcoholic fatty liver disease.”
MedlinePlus: “Fatty Liver Disease.”
Nutrients: “Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.”
Scientific Reports: “Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration.”
University of Michigan Health: “Alcohol Related Liver Disease.”
Yale Medicine: “FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease.”